Defining the role of 12-lipoxygenase in regulating platelet-derived extracellular vesicles
Biochemical Pharmacology · 2025
DOI: 10.1016/j.bcp.2025.117404 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Pharmacology, 2025. Verfasst von Alexis J Matthew und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, Université de Moncton, Moncton, Canada; New Brunswick Center for Precision Medicine, Moncton, Canada. Hauptthemen laut MEDLINE: Arachidonate 12-Lipoxygenase, Blood Platelets, Extracellular Vesicles. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: New Brunswick Innovation Foundation, Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Platelets are traditionally recognized for their role in hemostasis and wound repair, yet they also play a pivotal role in intercellular communication through the release of platelet-derived extracellular vesicles (PMVs). These vesicles contribute to diverse physiological and pathological processes, but the mechanisms governing their biogenesis remain incompletely understood. One candidate regulator is 12-lipoxygenase (12-LO), an enzyme that metabolizes arachidonic acid into the lipid mediator 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE). While 12-LO has been linked to coagulation and neutrophil interactions, its involvement in PMV production has not been clearly defined. In this study, we investigated the role of 12-LO in PMV biogenesis using both human and murine platelet models. Pharmacological inhibition of 12-LO significantly reduced 12(S)-HETE levels and PMV release in activated human platelets. Similarly, platelets from 12-LO-deficient (Alox12-/-) mice exhibited markedly impaired PMV production upon stimulation. Subpopulation analyses revealed agonist-specific effects of 12-LO deficiency on distinct PMV subsets, including mitochondrial-containing vesicles. Importantly, supplementation with exogenous 12(S)-HETE partially restored PMV production in Alox12-/- platelets, confirming the functional relevance of this lipid mediator. Together, these findings identify 12-LO as a critical regulator of PMV biogenesis and suggest that the 12-LO/12(S)-HETE axis represents a novel therapeutic target in inflammatory and thrombotic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, Université de Moncton, Moncton, Canada; New Brunswick Center for Precision Medicine, Moncton, Canada.
- Department of Chemistry and Biochemistry, Université de Moncton, Moncton, Canada.
- Department of Chemistry and Biochemistry, Université de Moncton, Moncton, Canada; Vitalité Health Network, Dr. Georges-L.-Dumont University Hospital Centre, Department of Molecular Genetics, Moncton, NB, Canada; Atlanti…
- Department of Chemistry and Biochemistry, Université de Moncton, Moncton, Canada; New Brunswick Center for Precision Medicine, Moncton, Canada. Electronic address: luc.boudreau@umoncton.ca.
Förderung
- New Brunswick Innovation Foundation
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Matthew, A. J., Richard, J. D., Gauvin, V. L., Hébert, M. P. A., Touaibia, M., Allain, E. P., & Boudreau, L. H. (2025). Defining the role of 12-lipoxygenase in regulating platelet-derived extracellular vesicles. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2025.117404
Vancouver
Matthew AJ, Richard JD, Gauvin VL, Hébert MPA, Touaibia M, Allain EP, et al. Defining the role of 12-lipoxygenase in regulating platelet-derived extracellular vesicles. Biochemical Pharmacology. 2025. doi:10.1016/j.bcp.2025.117404
BibTeX
@article{Matthew2025,
author = {Matthew, Alexis J and Richard, Jaël D and Gauvin, Vanessa L and Hébert, Mathieu P A and Touaibia, Mohamed and Allain, Eric P and Boudreau, Luc H},
title = {Defining the role of 12-lipoxygenase in regulating platelet-derived extracellular vesicles},
journal = {Biochemical Pharmacology},
year = {2025},
doi = {10.1016/j.bcp.2025.117404}
}
EUVIMED